Larkin JMG, et al. 5-year survival outcomes of the CheckMate 067 phase 3 trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma. Abstract LBA68_PR. ESMO Congress 2019, 28 sept, Barcelona, Spanje.
Nauwkeurigere chirurgie bij rectumcarcinoom met SGM-101
feb 2018 | Chirurgie, Maag-darm-leveroncologie